HOME > ARCHIVE
ARCHIVE
- 20% Tax Deduction to Be Allowed for 8 Medical Devices Designed to Prevent Accidents
March 24, 2003
- WORD NEWS IN BRIEF
March 24, 2003
- Safety Assurance Activities of New Drug Organization Outlined
March 24, 2003
- Pollinosis Intensifying Competition in Market for Allergy Treatments
March 24, 2003
- JABP, JRCS Report Cost Breakdowns for Plasma Fraction Preparations
March 24, 2003
- e-Detailing Makes Drs Deepen Their Knowledge: ACNielsen Survey
March 24, 2003
- REGULATORY NEWS IN BRIEF
March 24, 2003
- Targeted Treatment Solutions Needed: IBM Business Consulting Report
March 24, 2003
- MEDICAL FACILITIES & NURSING CARE NEWS IN BREIF
March 24, 2003
- Advanced Technologies Contributing to Cardiac Diseases: ACCJ Seminar
March 24, 2003
- NEW PRODUCTS
March 24, 2003
- Sumitomo Gets Rights to Develop, Market Glucophage in Japan From Merck-Sante
March 24, 2003
- OTC NEWS IN BREIF
March 24, 2003
- Scottish Biotech Industry Lures Japanese Firms: Seminar
March 24, 2003
- Patent Strategy Important in Venture Businesses: Dr. Morishita of AnGes MG
March 24, 2003
- Cerebral Infarction Patients, Families Still Resisting Generics: LCA-J Survey
March 24, 2003
- GLs on Use of Biological Products to Treat RA Completed: Korosho Panel
March 24, 2003
- Drug-related Patent Applications Up Sharply in 2002: Patolis Survey
March 17, 2003
- OTC NEWS IN BRIEF
March 17, 2003
- BUSINESS NEWS IN BRIEF
March 17, 2003
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
